CCL11 and Alzheimer disease: No differences between the three groups were identified for the remaining inflammatory mediators (IL1-β, IL-6, IL-8, Eotaxin, Eotaxin-3, IP10, MDC, MIP-1α, MIP-1β, TARC, SAA, PIGF) with the exception of IL-5, where a slight decrease was observed in the moderate AD group compared with control (p = 0.034).